SLNO logo

Soleno Therapeutics (SLNO) Current Liabilities

Annual Current Liabilities

$11.51 M
+$4.19 M+57.32%

31 December 2023

SLNO Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$14.96 M
+$5.81 M+63.52%

30 September 2024

SLNO Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SLNO Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+57.3%-48.4%
3 y3 years+33.5%+65.5%
5 y5 years+513.0%+333.2%

SLNO Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+57.3%-48.4%+106.5%
5 y5 yearsat high+513.0%-48.4%+333.2%
alltimeall time-18.9%+792.0%-48.4%+1417.9%

Soleno Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$14.96 M(+63.5%)
June 2024
-
$9.15 M(-32.0%)
Mar 2024
-
$13.46 M(+17.0%)
Dec 2023
$11.51 M(+57.3%)
$11.51 M(-60.3%)
Sept 2023
-
$28.99 M(+229.5%)
June 2023
-
$8.80 M(+13.4%)
Mar 2023
-
$7.76 M(+6.1%)
Dec 2022
$7.31 M(-8.7%)
$7.31 M(-0.4%)
Sept 2022
-
$7.34 M(+1.3%)
June 2022
-
$7.25 M(-0.9%)
Mar 2022
-
$7.31 M(-8.7%)
Dec 2021
$8.01 M(-7.1%)
$8.01 M(-11.4%)
Sept 2021
-
$9.04 M(+8.1%)
June 2021
-
$8.36 M(-12.1%)
Mar 2021
-
$9.51 M(+10.3%)
Dec 2020
$8.62 M(+73.6%)
$8.62 M(+7.8%)
Sept 2020
-
$8.00 M(-4.4%)
June 2020
-
$8.36 M(+14.8%)
Mar 2020
-
$7.29 M(+46.8%)
Dec 2019
$4.96 M
$4.96 M(+43.7%)
Sept 2019
-
$3.45 M(+21.0%)
June 2019
-
$2.85 M(+26.9%)
DateAnnualQuarterly
Mar 2019
-
$2.25 M(+19.9%)
Dec 2018
$1.88 M(+8.3%)
$1.88 M(-25.2%)
Sept 2018
-
$2.51 M(+28.9%)
June 2018
-
$1.95 M(+0.2%)
Mar 2018
-
$1.94 M(+12.1%)
Dec 2017
$1.73 M(+1.5%)
$1.73 M(+0.1%)
Sept 2017
-
$1.73 M(-18.4%)
June 2017
-
$2.12 M(-2.3%)
Mar 2017
-
$2.17 M(+27.2%)
Dec 2016
$1.71 M(-46.5%)
$1.71 M(-3.9%)
Sept 2016
-
$1.78 M(-6.5%)
June 2016
-
$1.90 M(-26.3%)
Mar 2016
-
$2.58 M(-19.2%)
Dec 2015
$3.19 M(+147.5%)
$3.19 M(-47.0%)
Sept 2015
-
$6.03 M(-54.8%)
June 2015
-
$13.35 M(+1160.5%)
Mar 2015
-
$1.06 M(-17.9%)
Dec 2014
$1.29 M(-90.9%)
$1.29 M(-19.2%)
Sept 2014
-
$1.60 M(+61.9%)
June 2014
-
$985.70 K(-93.3%)
Mar 2014
-
$14.69 M(+3.6%)
Dec 2013
$14.18 M(+22.8%)
$14.18 M
Dec 2012
$11.54 M
-

FAQ

  • What is Soleno Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Soleno Therapeutics?
  • What is Soleno Therapeutics annual current liabilities year-on-year change?
  • What is Soleno Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly current liabilities year-on-year change?

What is Soleno Therapeutics annual total current liabilities?

The current annual current liabilities of SLNO is $11.51 M

What is the all time high annual current liabilities for Soleno Therapeutics?

Soleno Therapeutics all-time high annual total current liabilities is $14.18 M

What is Soleno Therapeutics annual current liabilities year-on-year change?

Over the past year, SLNO annual total current liabilities has changed by +$4.19 M (+57.32%)

What is Soleno Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of SLNO is $14.96 M

What is the all time high quarterly current liabilities for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly total current liabilities is $28.99 M

What is Soleno Therapeutics quarterly current liabilities year-on-year change?

Over the past year, SLNO quarterly total current liabilities has changed by -$14.03 M (-48.39%)